Clinical trials
Enrolling by invitation Neoplasms trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
37 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 10 |
| 2026 | 14 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 37 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Abramson Cancer Center at Penn Medicine | 2 |
| Ponce Medical School Foundation, Inc. | 2 |
| Rutgers, The State University of New Jersey | 2 |
| Aarhus University Hospital | 1 |
| Agri Ibrahim Cecen University | 1 |
| American Cancer Society Cancer Action Network | 1 |
| Centre Hospitalier Universitaire Vaudois | 1 |
| Duke University | 1 |
| Ellis Medicine | 1 |
| Harvard Medical School (HMS and HSDM) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 37 |
| Anxiety Disorders | 3 |
| Adenocarcinoma | 1 |
| Adenocarcinoma in Situ | 1 |
| Breast Neoplasms | 1 |
| Carcinoma | 1 |
| Carcinoma in Situ | 1 |
| Carcinoma, Hepatocellular | 1 |
| Carcinoma, Renal Cell | 1 |
| Cytokine Release Syndrome | 1 |
Trials
Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.